ID: ALA4462393

Max Phase: Preclinical

Molecular Formula: C12H20N6O7

Molecular Weight: 360.33

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@@H](NC(=O)N[C@@H](CC(N)=O)c1nc([C@@H](N)CO)no1)C(=O)O

Standard InChI:  InChI=1S/C12H20N6O7/c1-4(20)8(11(22)23)16-12(24)15-6(2-7(14)21)10-17-9(18-25-10)5(13)3-19/h4-6,8,19-20H,2-3,13H2,1H3,(H2,14,21)(H,22,23)(H2,15,16,24)/t4-,5+,6+,8-/m1/s1

Standard InChI Key:  HFOBENSCBRZVSP-FZGKIIIMSA-N

Associated Targets(Human)

V-type immunoglobulin domain-containing suppressor of T-cell activation 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Programmed cell death 1 ligand 1 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.33Molecular Weight (Monoisotopic): 360.1393AlogP: -2.89#Rotatable Bonds: 9
Polar Surface Area: 226.92Molecular Species: ACIDHBA: 9HBD: 7
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.50CX Basic pKa: 6.97CX LogP: -5.95CX LogD: -6.43
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.24Np Likeness Score: -0.60

References

1. Wang T, Wu X, Guo C, Zhang K, Xu J, Li Z, Jiang S..  (2019)  Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.,  62  (4): [PMID:30247903] [10.1021/acs.jmedchem.8b00990]

Source